Research Reports in Clinical Cardiology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2144885, encodeId=d04a214488564, content=这和Clinical Research in Cardiology 是一个杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Mon Jun 26 21:59:24 CST 2023, time=2023-06-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590622, encodeId=2a2e590622ae, content=需要版面费吗westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589525, encodeId=ed79589525da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1e8p1HhRm9Oh8LlQ7uUwkWnI0hjQd5iaPeaibFDgJPuS8Qvk6gmdHniaYa7icHGR0rtlAcMgjJqSPDicqL6a4Vyzg1Q/132, createdBy=6b9132243, createdName=westonli, createdTime=Thu Apr 23 09:40:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855316, encodeId=86eb855316c6, content=杂志是德国主办，非常有效率，3 周收到审稿建议，修完后一周内回复录用与否，1 个月搞定，真心为高效率点赞！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Wed Nov 27 09:41:49 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801119, encodeId=ef2e80111983, content=这个杂志自引率这么高，会不会被剔除啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=ms5000000875331228, createdTime=Fri Jul 03 22:46:57 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582600, encodeId=498d582600a5, content=你交了审稿费吗采彩 2018-11-03 00:00:00 发表: 后来选的啥 , beContent=采彩 2018-11-03 00:00:00 发表: 后来选的啥 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220106/e7ff7615ccd247d189cfd37996f92123/43f8fa6f344048c78b9d251ca407c348.jpg, createdBy=24312490372, createdName=12479015m50(暂无昵称), createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562686, encodeId=8539562686fb, content=后来选的啥 jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。jasonyao 2015-10-18 22:42:00 发表: 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, beContent=jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170227/IMG58B42AE5884647372.jpg, createdBy=8bc32027677, createdName=采彩, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543983, encodeId=0a8154398376, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533648, encodeId=0b8453364866, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：可以说，这个期刊是拒稿速度最快的。相信命中率低于20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 02 20:46:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526421, encodeId=f2115264214e, content=同问1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, beContent=1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9A2A077E0207ADFAAFE91B0AB39A3944/100, createdBy=77231943546, createdName=linn89, createdTime=Sun Aug 28 11:55:00 CST 2016, time=2016-08-28, status=1, ipAttribution=)]

2023-06-26 ms8000000757755021 来自广东省

这和Clinical Research in Cardiology 是一个杂志吗

78 0

[GetPortalCommentsPageByObjectIdResponse(id=2144885, encodeId=d04a214488564, content=这和Clinical Research in Cardiology 是一个杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Mon Jun 26 21:59:24 CST 2023, time=2023-06-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590622, encodeId=2a2e590622ae, content=需要版面费吗westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589525, encodeId=ed79589525da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1e8p1HhRm9Oh8LlQ7uUwkWnI0hjQd5iaPeaibFDgJPuS8Qvk6gmdHniaYa7icHGR0rtlAcMgjJqSPDicqL6a4Vyzg1Q/132, createdBy=6b9132243, createdName=westonli, createdTime=Thu Apr 23 09:40:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855316, encodeId=86eb855316c6, content=杂志是德国主办，非常有效率，3 周收到审稿建议，修完后一周内回复录用与否，1 个月搞定，真心为高效率点赞！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Wed Nov 27 09:41:49 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801119, encodeId=ef2e80111983, content=这个杂志自引率这么高，会不会被剔除啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=ms5000000875331228, createdTime=Fri Jul 03 22:46:57 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582600, encodeId=498d582600a5, content=你交了审稿费吗采彩 2018-11-03 00:00:00 发表: 后来选的啥 , beContent=采彩 2018-11-03 00:00:00 发表: 后来选的啥 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220106/e7ff7615ccd247d189cfd37996f92123/43f8fa6f344048c78b9d251ca407c348.jpg, createdBy=24312490372, createdName=12479015m50(暂无昵称), createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562686, encodeId=8539562686fb, content=后来选的啥 jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。jasonyao 2015-10-18 22:42:00 发表: 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, beContent=jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170227/IMG58B42AE5884647372.jpg, createdBy=8bc32027677, createdName=采彩, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543983, encodeId=0a8154398376, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533648, encodeId=0b8453364866, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：可以说，这个期刊是拒稿速度最快的。相信命中率低于20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 02 20:46:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526421, encodeId=f2115264214e, content=同问1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, beContent=1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9A2A077E0207ADFAAFE91B0AB39A3944/100, createdBy=77231943546, createdName=linn89, createdTime=Sun Aug 28 11:55:00 CST 2016, time=2016-08-28, status=1, ipAttribution=)]

2020-05-11 甄惜2627

需要版面费吗westonli 2020-04-23 09:40:00 发表:
2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。
Received 26 March 2020
Accepted 06 April 2020
Published 21 April 2020

westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。
Received 26 March 2020
Accepted 06 April 2020
Published 21 April 2020

134 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2144885, encodeId=d04a214488564, content=这和Clinical Research in Cardiology 是一个杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Mon Jun 26 21:59:24 CST 2023, time=2023-06-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590622, encodeId=2a2e590622ae, content=需要版面费吗westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589525, encodeId=ed79589525da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1e8p1HhRm9Oh8LlQ7uUwkWnI0hjQd5iaPeaibFDgJPuS8Qvk6gmdHniaYa7icHGR0rtlAcMgjJqSPDicqL6a4Vyzg1Q/132, createdBy=6b9132243, createdName=westonli, createdTime=Thu Apr 23 09:40:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855316, encodeId=86eb855316c6, content=杂志是德国主办，非常有效率，3 周收到审稿建议，修完后一周内回复录用与否，1 个月搞定，真心为高效率点赞！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Wed Nov 27 09:41:49 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801119, encodeId=ef2e80111983, content=这个杂志自引率这么高，会不会被剔除啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=ms5000000875331228, createdTime=Fri Jul 03 22:46:57 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582600, encodeId=498d582600a5, content=你交了审稿费吗采彩 2018-11-03 00:00:00 发表: 后来选的啥 , beContent=采彩 2018-11-03 00:00:00 发表: 后来选的啥 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220106/e7ff7615ccd247d189cfd37996f92123/43f8fa6f344048c78b9d251ca407c348.jpg, createdBy=24312490372, createdName=12479015m50(暂无昵称), createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562686, encodeId=8539562686fb, content=后来选的啥 jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。jasonyao 2015-10-18 22:42:00 发表: 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, beContent=jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170227/IMG58B42AE5884647372.jpg, createdBy=8bc32027677, createdName=采彩, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543983, encodeId=0a8154398376, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533648, encodeId=0b8453364866, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：可以说，这个期刊是拒稿速度最快的。相信命中率低于20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 02 20:46:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526421, encodeId=f2115264214e, content=同问1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, beContent=1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9A2A077E0207ADFAAFE91B0AB39A3944/100, createdBy=77231943546, createdName=linn89, createdTime=Sun Aug 28 11:55:00 CST 2016, time=2016-08-28, status=1, ipAttribution=)]

2020-04-23 westonli

审稿速度:1.0 | 投稿命中率:75.0
经验分享：2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。
Received 26 March 2020
Accepted 06 April 2020
Published 21 April 2020

132 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2144885, encodeId=d04a214488564, content=这和Clinical Research in Cardiology 是一个杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Mon Jun 26 21:59:24 CST 2023, time=2023-06-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590622, encodeId=2a2e590622ae, content=需要版面费吗westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589525, encodeId=ed79589525da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1e8p1HhRm9Oh8LlQ7uUwkWnI0hjQd5iaPeaibFDgJPuS8Qvk6gmdHniaYa7icHGR0rtlAcMgjJqSPDicqL6a4Vyzg1Q/132, createdBy=6b9132243, createdName=westonli, createdTime=Thu Apr 23 09:40:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855316, encodeId=86eb855316c6, content=杂志是德国主办，非常有效率，3 周收到审稿建议，修完后一周内回复录用与否，1 个月搞定，真心为高效率点赞！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Wed Nov 27 09:41:49 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801119, encodeId=ef2e80111983, content=这个杂志自引率这么高，会不会被剔除啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=ms5000000875331228, createdTime=Fri Jul 03 22:46:57 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582600, encodeId=498d582600a5, content=你交了审稿费吗采彩 2018-11-03 00:00:00 发表: 后来选的啥 , beContent=采彩 2018-11-03 00:00:00 发表: 后来选的啥 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220106/e7ff7615ccd247d189cfd37996f92123/43f8fa6f344048c78b9d251ca407c348.jpg, createdBy=24312490372, createdName=12479015m50(暂无昵称), createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562686, encodeId=8539562686fb, content=后来选的啥 jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。jasonyao 2015-10-18 22:42:00 发表: 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, beContent=jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170227/IMG58B42AE5884647372.jpg, createdBy=8bc32027677, createdName=采彩, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543983, encodeId=0a8154398376, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533648, encodeId=0b8453364866, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：可以说，这个期刊是拒稿速度最快的。相信命中率低于20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 02 20:46:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526421, encodeId=f2115264214e, content=同问1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, beContent=1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9A2A077E0207ADFAAFE91B0AB39A3944/100, createdBy=77231943546, createdName=linn89, createdTime=Sun Aug 28 11:55:00 CST 2016, time=2016-08-28, status=1, ipAttribution=)]

2019-11-27 ms6291048970344522

杂志是德国主办，非常有效率，3 周收到审稿建议，修完后一周内回复录用与否，1 个月搞定，真心为高效率点赞！

126 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2144885, encodeId=d04a214488564, content=这和Clinical Research in Cardiology 是一个杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Mon Jun 26 21:59:24 CST 2023, time=2023-06-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590622, encodeId=2a2e590622ae, content=需要版面费吗westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589525, encodeId=ed79589525da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1e8p1HhRm9Oh8LlQ7uUwkWnI0hjQd5iaPeaibFDgJPuS8Qvk6gmdHniaYa7icHGR0rtlAcMgjJqSPDicqL6a4Vyzg1Q/132, createdBy=6b9132243, createdName=westonli, createdTime=Thu Apr 23 09:40:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855316, encodeId=86eb855316c6, content=杂志是德国主办，非常有效率，3 周收到审稿建议，修完后一周内回复录用与否，1 个月搞定，真心为高效率点赞！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Wed Nov 27 09:41:49 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801119, encodeId=ef2e80111983, content=这个杂志自引率这么高，会不会被剔除啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=ms5000000875331228, createdTime=Fri Jul 03 22:46:57 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582600, encodeId=498d582600a5, content=你交了审稿费吗采彩 2018-11-03 00:00:00 发表: 后来选的啥 , beContent=采彩 2018-11-03 00:00:00 发表: 后来选的啥 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220106/e7ff7615ccd247d189cfd37996f92123/43f8fa6f344048c78b9d251ca407c348.jpg, createdBy=24312490372, createdName=12479015m50(暂无昵称), createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562686, encodeId=8539562686fb, content=后来选的啥 jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。jasonyao 2015-10-18 22:42:00 发表: 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, beContent=jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170227/IMG58B42AE5884647372.jpg, createdBy=8bc32027677, createdName=采彩, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543983, encodeId=0a8154398376, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533648, encodeId=0b8453364866, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：可以说，这个期刊是拒稿速度最快的。相信命中率低于20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 02 20:46:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526421, encodeId=f2115264214e, content=同问1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, beContent=1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9A2A077E0207ADFAAFE91B0AB39A3944/100, createdBy=77231943546, createdName=linn89, createdTime=Sun Aug 28 11:55:00 CST 2016, time=2016-08-28, status=1, ipAttribution=)]

2020-07-03 ms5000000875331228

这个杂志自引率这么高，会不会被剔除啊？

139 0

[GetPortalCommentsPageByObjectIdResponse(id=2144885, encodeId=d04a214488564, content=这和Clinical Research in Cardiology 是一个杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Mon Jun 26 21:59:24 CST 2023, time=2023-06-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590622, encodeId=2a2e590622ae, content=需要版面费吗westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589525, encodeId=ed79589525da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1e8p1HhRm9Oh8LlQ7uUwkWnI0hjQd5iaPeaibFDgJPuS8Qvk6gmdHniaYa7icHGR0rtlAcMgjJqSPDicqL6a4Vyzg1Q/132, createdBy=6b9132243, createdName=westonli, createdTime=Thu Apr 23 09:40:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855316, encodeId=86eb855316c6, content=杂志是德国主办，非常有效率，3 周收到审稿建议，修完后一周内回复录用与否，1 个月搞定，真心为高效率点赞！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Wed Nov 27 09:41:49 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801119, encodeId=ef2e80111983, content=这个杂志自引率这么高，会不会被剔除啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=ms5000000875331228, createdTime=Fri Jul 03 22:46:57 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582600, encodeId=498d582600a5, content=你交了审稿费吗采彩 2018-11-03 00:00:00 发表: 后来选的啥 , beContent=采彩 2018-11-03 00:00:00 发表: 后来选的啥 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220106/e7ff7615ccd247d189cfd37996f92123/43f8fa6f344048c78b9d251ca407c348.jpg, createdBy=24312490372, createdName=12479015m50(暂无昵称), createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562686, encodeId=8539562686fb, content=后来选的啥 jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。jasonyao 2015-10-18 22:42:00 发表: 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, beContent=jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170227/IMG58B42AE5884647372.jpg, createdBy=8bc32027677, createdName=采彩, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543983, encodeId=0a8154398376, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533648, encodeId=0b8453364866, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：可以说，这个期刊是拒稿速度最快的。相信命中率低于20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 02 20:46:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526421, encodeId=f2115264214e, content=同问1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, beContent=1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9A2A077E0207ADFAAFE91B0AB39A3944/100, createdBy=77231943546, createdName=linn89, createdTime=Sun Aug 28 11:55:00 CST 2016, time=2016-08-28, status=1, ipAttribution=)]

2020-01-03 12479015m50(暂无昵称)

你交了审稿费吗采彩 2018-11-03 00:00:00 发表:
后来选的啥

采彩 2018-11-03 00:00:00 发表: 后来选的啥

169 0

[GetPortalCommentsPageByObjectIdResponse(id=2144885, encodeId=d04a214488564, content=这和Clinical Research in Cardiology 是一个杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Mon Jun 26 21:59:24 CST 2023, time=2023-06-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590622, encodeId=2a2e590622ae, content=需要版面费吗westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589525, encodeId=ed79589525da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1e8p1HhRm9Oh8LlQ7uUwkWnI0hjQd5iaPeaibFDgJPuS8Qvk6gmdHniaYa7icHGR0rtlAcMgjJqSPDicqL6a4Vyzg1Q/132, createdBy=6b9132243, createdName=westonli, createdTime=Thu Apr 23 09:40:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855316, encodeId=86eb855316c6, content=杂志是德国主办，非常有效率，3 周收到审稿建议，修完后一周内回复录用与否，1 个月搞定，真心为高效率点赞！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Wed Nov 27 09:41:49 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801119, encodeId=ef2e80111983, content=这个杂志自引率这么高，会不会被剔除啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=ms5000000875331228, createdTime=Fri Jul 03 22:46:57 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582600, encodeId=498d582600a5, content=你交了审稿费吗采彩 2018-11-03 00:00:00 发表: 后来选的啥 , beContent=采彩 2018-11-03 00:00:00 发表: 后来选的啥 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220106/e7ff7615ccd247d189cfd37996f92123/43f8fa6f344048c78b9d251ca407c348.jpg, createdBy=24312490372, createdName=12479015m50(暂无昵称), createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562686, encodeId=8539562686fb, content=后来选的啥 jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。jasonyao 2015-10-18 22:42:00 发表: 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, beContent=jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170227/IMG58B42AE5884647372.jpg, createdBy=8bc32027677, createdName=采彩, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543983, encodeId=0a8154398376, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533648, encodeId=0b8453364866, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：可以说，这个期刊是拒稿速度最快的。相信命中率低于20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 02 20:46:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526421, encodeId=f2115264214e, content=同问1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, beContent=1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9A2A077E0207ADFAAFE91B0AB39A3944/100, createdBy=77231943546, createdName=linn89, createdTime=Sun Aug 28 11:55:00 CST 2016, time=2016-08-28, status=1, ipAttribution=)]

2018-11-03 采彩

后来选的啥 jasonyao 2015-10-18 发表::
SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。jasonyao 2015-10-18 22:42:00 发表:
投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。

jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。

313 0

[GetPortalCommentsPageByObjectIdResponse(id=2144885, encodeId=d04a214488564, content=这和Clinical Research in Cardiology 是一个杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Mon Jun 26 21:59:24 CST 2023, time=2023-06-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590622, encodeId=2a2e590622ae, content=需要版面费吗westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589525, encodeId=ed79589525da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1e8p1HhRm9Oh8LlQ7uUwkWnI0hjQd5iaPeaibFDgJPuS8Qvk6gmdHniaYa7icHGR0rtlAcMgjJqSPDicqL6a4Vyzg1Q/132, createdBy=6b9132243, createdName=westonli, createdTime=Thu Apr 23 09:40:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855316, encodeId=86eb855316c6, content=杂志是德国主办，非常有效率，3 周收到审稿建议，修完后一周内回复录用与否，1 个月搞定，真心为高效率点赞！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Wed Nov 27 09:41:49 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801119, encodeId=ef2e80111983, content=这个杂志自引率这么高，会不会被剔除啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=ms5000000875331228, createdTime=Fri Jul 03 22:46:57 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582600, encodeId=498d582600a5, content=你交了审稿费吗采彩 2018-11-03 00:00:00 发表: 后来选的啥 , beContent=采彩 2018-11-03 00:00:00 发表: 后来选的啥 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220106/e7ff7615ccd247d189cfd37996f92123/43f8fa6f344048c78b9d251ca407c348.jpg, createdBy=24312490372, createdName=12479015m50(暂无昵称), createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562686, encodeId=8539562686fb, content=后来选的啥 jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。jasonyao 2015-10-18 22:42:00 发表: 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, beContent=jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170227/IMG58B42AE5884647372.jpg, createdBy=8bc32027677, createdName=采彩, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543983, encodeId=0a8154398376, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533648, encodeId=0b8453364866, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：可以说，这个期刊是拒稿速度最快的。相信命中率低于20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 02 20:46:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526421, encodeId=f2115264214e, content=同问1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, beContent=1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9A2A077E0207ADFAAFE91B0AB39A3944/100, createdBy=77231943546, createdName=linn89, createdTime=Sun Aug 28 11:55:00 CST 2016, time=2016-08-28, status=1, ipAttribution=)]

2017-07-16 wang_di98

徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

429 0

[GetPortalCommentsPageByObjectIdResponse(id=2144885, encodeId=d04a214488564, content=这和Clinical Research in Cardiology 是一个杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Mon Jun 26 21:59:24 CST 2023, time=2023-06-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590622, encodeId=2a2e590622ae, content=需要版面费吗westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589525, encodeId=ed79589525da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1e8p1HhRm9Oh8LlQ7uUwkWnI0hjQd5iaPeaibFDgJPuS8Qvk6gmdHniaYa7icHGR0rtlAcMgjJqSPDicqL6a4Vyzg1Q/132, createdBy=6b9132243, createdName=westonli, createdTime=Thu Apr 23 09:40:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855316, encodeId=86eb855316c6, content=杂志是德国主办，非常有效率，3 周收到审稿建议，修完后一周内回复录用与否，1 个月搞定，真心为高效率点赞！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Wed Nov 27 09:41:49 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801119, encodeId=ef2e80111983, content=这个杂志自引率这么高，会不会被剔除啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=ms5000000875331228, createdTime=Fri Jul 03 22:46:57 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582600, encodeId=498d582600a5, content=你交了审稿费吗采彩 2018-11-03 00:00:00 发表: 后来选的啥 , beContent=采彩 2018-11-03 00:00:00 发表: 后来选的啥 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220106/e7ff7615ccd247d189cfd37996f92123/43f8fa6f344048c78b9d251ca407c348.jpg, createdBy=24312490372, createdName=12479015m50(暂无昵称), createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562686, encodeId=8539562686fb, content=后来选的啥 jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。jasonyao 2015-10-18 22:42:00 发表: 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, beContent=jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170227/IMG58B42AE5884647372.jpg, createdBy=8bc32027677, createdName=采彩, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543983, encodeId=0a8154398376, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533648, encodeId=0b8453364866, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：可以说，这个期刊是拒稿速度最快的。相信命中率低于20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 02 20:46:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526421, encodeId=f2115264214e, content=同问1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, beContent=1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9A2A077E0207ADFAAFE91B0AB39A3944/100, createdBy=77231943546, createdName=linn89, createdTime=Sun Aug 28 11:55:00 CST 2016, time=2016-08-28, status=1, ipAttribution=)]

2017-03-02 bigOne

审稿速度:1.0 | 投稿命中率:5.0
经验分享：可以说，这个期刊是拒稿速度最快的。相信命中率低于20%

400 0

[GetPortalCommentsPageByObjectIdResponse(id=2144885, encodeId=d04a214488564, content=这和Clinical Research in Cardiology 是一个杂志吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f995638061, createdName=ms8000000757755021, createdTime=Mon Jun 26 21:59:24 CST 2023, time=2023-06-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=590622, encodeId=2a2e590622ae, content=需要版面费吗westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=westonli 2020-04-23 09:40:00 发表: 2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/12/3e096ca1048103dc9ea7aca7f61e988e.jpg, createdBy=7be22089623, createdName=甄惜2627, createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589525, encodeId=ed79589525da, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2020年投稿一个case report，以letter形式，一审2周接受，编辑和review意见都是赞成的2周后见刊，不收取任何费用，是心血管个案比较好的临床杂志，不过病例需要新颖。 Received 26 March 2020 Accepted 06 April 2020 Published 21 April 2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1e8p1HhRm9Oh8LlQ7uUwkWnI0hjQd5iaPeaibFDgJPuS8Qvk6gmdHniaYa7icHGR0rtlAcMgjJqSPDicqL6a4Vyzg1Q/132, createdBy=6b9132243, createdName=westonli, createdTime=Thu Apr 23 09:40:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855316, encodeId=86eb855316c6, content=杂志是德国主办，非常有效率，3 周收到审稿建议，修完后一周内回复录用与否，1 个月搞定，真心为高效率点赞！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Wed Nov 27 09:41:49 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801119, encodeId=ef2e80111983, content=这个杂志自引率这么高，会不会被剔除啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=ms5000000875331228, createdTime=Fri Jul 03 22:46:57 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582600, encodeId=498d582600a5, content=你交了审稿费吗采彩 2018-11-03 00:00:00 发表: 后来选的啥 , beContent=采彩 2018-11-03 00:00:00 发表: 后来选的啥 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220106/e7ff7615ccd247d189cfd37996f92123/43f8fa6f344048c78b9d251ca407c348.jpg, createdBy=24312490372, createdName=12479015m50(暂无昵称), createdTime=Fri Jan 03 00:00:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562686, encodeId=8539562686fb, content=后来选的啥 jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。jasonyao 2015-10-18 22:42:00 发表: 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, beContent=jasonyao 2015-10-18 发表:: SCI(2014)：4.56 投了一篇，几天后直接被拒。后来选了篇2分左右的中了。感觉要求还是比较高的，一般的临床文章估计没戏。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170227/IMG58B42AE5884647372.jpg, createdBy=8bc32027677, createdName=采彩, createdTime=Sat Nov 03 00:00:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543983, encodeId=0a8154398376, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533648, encodeId=0b8453364866, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：可以说，这个期刊是拒稿速度最快的。相信命中率低于20%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Thu Mar 02 20:46:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526421, encodeId=f2115264214e, content=同问1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, beContent=1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9A2A077E0207ADFAAFE91B0AB39A3944/100, createdBy=77231943546, createdName=linn89, createdTime=Sun Aug 28 11:55:00 CST 2016, time=2016-08-28, status=1, ipAttribution=)]

2016-08-28 linn89

同问1570341****(暂无匿称) 2016-08-07 发表::
请问下同胞们，这个杂志接收个案报道吗

1570341****(暂无匿称) 2016-08-07 发表:: 请问下同胞们，这个杂志接收个案报道吗

442 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务